References |
"cDNA cloning and chromosomal localization of the human beta-adrenergic receptor kinase.";,Benovic J.L., Stone W.C., Huebner K., Croce C., Caron M.G.,Lefkowitz R.J.;,FEBS Lett. 283:122-126(1991)., PubMeb:2037065 DOI:10.1016/0014-5793(91)80568-N
"High expression of beta-adrenergic receptor kinase in humanperipheral blood leukocytes. Isoproterenol and platelet activatingfactor can induce kinase translocation.";,Chuang T.T., Sallese M., Ambrosini G., Parruti G., de Blasi A.;,J. Biol. Chem. 267:6886-6892(1992)., PubMeb:1339451
"Structure of the human gene encoding the beta-adrenergic receptorkinase.";,Penn R.B., Benovic J.L.;,J. Biol. Chem. 269:14924-14930(1994)., PubMeb:8195124
Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
"The status, quality, and expansion of the NIH full-length cDNAproject: the Mammalian Gene Collection (MGC).";,Genome Res. 14:2121-2127(2004).,PubMeb:15489334 DOI:10.1101/gr.2596504
"Monocyte chemoattractant protein-1-induced CCR2B receptordesensitization mediated by the G protein-coupled receptor kinase 2.";,Aragay A.M., Mellado M., Frade J.M., Martin A.M., Jimenez-Sainz M.C.,Martinez-A C., Mayor F. Jr.;,Proc. Natl. Acad. Sci. U.S.A. 95:2985-2990(1998).,PubMeb:9501202 DOI:10.1073/pnas.95.6.2985
"Differential effects of CC chemokines on CC chemokine receptor 5(CCR5) phosphorylation and identification of phosphorylation sites onthe CCR5 carboxyl terminus.";,Oppermann M., Mack M., Proudfoot A.E., Olbrich H.;,J. Biol. Chem. 274:8875-8885(1999).,PubMeb:10085131 DOI:10.1074/jbc.274.13.8875
"Phosphoproteome of resting human platelets.";,Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;,J. Proteome Res. 7:526-534(2008).,PubMeb:18088087 DOI:10.1021/pr0704130
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";,Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;,Anal. Chem. 81:4493-4501(2009).,PubMeb:19413330 DOI:10.1021/ac9004309
"Large-scale proteomics analysis of the human kinome.";,Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;,Mol. Cell. Proteomics 8:1751-1764(2009).,PubMeb:19369195 DOI:10.1074/mcp.M800588-MCP200
"Dual regulation of lysophosphatidic acid (LPA1) receptor signallingby Ral and GRK.";,Aziziyeh A.I., Li T.T., Pape C., Pampillo M., Chidiac P.,Possmayer F., Babwah A.V., Bhattacharya M.;,Cell. Signal. 21:1207-1217(2009).,PubMeb:19306925 DOI:10.1016/j.cellsig.2009.03.011
"Initial characterization of the human central proteome.";,Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;,BMC Syst. Biol. 5:17-17(2011).,PubMeb:21269460 DOI:10.1186/1752-0509-5-17
"The solution structure and dynamics of the pleckstrin homology domainof G protein-coupled receptor kinase 2 (beta-adrenergic receptorkinase 1). A binding partner of Gbetagamma subunits.";,Fushman D., Najmabadi-Haske T., Cahill S., Zheng J., Levine H. III,Cowburn D.;,J. Biol. Chem. 273:2835-2843(1998)., PubMeb:9446593 DOI:10.1074/jbc.273.5.2835
"Patterns of somatic mutation in human cancer genomes.";,Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;,Nature 446:153-158(2007).,PubMeb:17344846 DOI:10.1038/nature05610 |
